PennyPulse
Apply
Closed Beta  ·  Biotech & Small-Cap Data

Data-driven research for
penny stocks & biotech companies

PennyPulse aggregates SEC filings, FDA events, patent data, clinical trials, and AI-generated summaries into one research platform — so you spend less time searching and more time understanding.

Apply for Access Explore the platform
1,200+Biotech & small-cap tickers
LiveSEC filing data
5+Integrated data sources
AIPowered summarisation
Platform

One platform. All the data.

Built specifically for biotech and small-cap equities, PennyPulse surfaces the public information that matters — consolidated, searchable, and summarised.

AI SummariesClaude-powered summaries of SEC filings, FDA events, and news — structured and delivered to your inbox on demand.
SEC FilingsBrowse and search 10-K, 10-Q, 8-K, S-1, and other filings with direct links to source documents on EDGAR.
FDA EventsTrack PDUFA dates, approval decisions, clinical holds, and warning letters for the biotech tickers you follow.
Patent DataMonitor patent filings and IP activity for pharma and biotech companies to understand their pipeline and competitive position.
Price AlertsConfigure email alerts for any ticker at any price threshold. Alerts are processed server-side — no app required.
WatchlistBuild and manage a watchlist with live prices, percentage change, volume, and a summary dashboard across all your tickers.
NewsCurated news from multiple sources, filtered to your watchlist tickers. Sourced directly — not aggregated from blogs.
Clinical TrialsLinked ClinicalTrials.gov data for active and completed studies, including phase, status, and enrolment information.
AI Summaries

Less searching.
More understanding.

Request an AI-generated research summary for any ticker. PennyPulse compiles recent SEC filings, FDA events, patent data, and news — then produces a structured, plain-language overview sent directly to your inbox.

AI summaries are for informational purposes only and do not constitute financial or investment advice. Always verify information from primary sources.

— Recent SEC filing overview
— FDA event timeline for the company
— Patent and pipeline activity summary
— Recent news digest
Research Summary Request
AI Summary — on demand
Delivered by email
01
Select a ticker
From your watchlist or any tracked stock
02
Request summary
One click from the stock detail page
03
Receive your summary
Structured report delivered to your inbox

Summaries are generated using publicly available data. PennyPulse does not provide investment advice or recommendations.

Data Sources

Where the data comes from

PennyPulse draws from both primary official databases and curated secondary sources. Primary data comes directly from regulatory and government bodies; secondary data is sourced from third-party providers and may have different update frequencies.

SEC EDGARPrimary
US securities filings and disclosures
FDAPrimary
Drug approvals, events and regulatory data
ClinicalTrials.govPrimary
Clinical study registry and trial status
Patent DatabasesPrimary
IP filings and patent activity
Market DataSecondary
Prices, volume and trading information
News & MediaSecondary
Curated news aggregated from multiple feeds
Getting started

Access is by invitation

1
Request access
Submit your name and email address. We review all requests individually.
2
Receive an invite
Approved users receive a login link by email. No passwords — sign in with Google.
3
Start researching
Full platform access from day one. Build a watchlist, track filings, and request AI summaries.
Invite-only beta

Apply for access

PennyPulse is in closed beta. Approved participants get full access at no cost during the beta period. We review every application personally.

Apply for Access No credit card · Google login